We and others have demonstrated that Aldehyde dehydrogenase 1A1-positive (ALDH1A1+) DANs in the ventral tier of SNc are particularly vulnerable in individuals with PD, as well as in PD-related rodent and primate models[5–9]. The gene discussed is ALDH1A1; the disease is Parkinson disease.